Siga Technologies Inc (SIGA) - News Archive

Expansion of TEPOXX (Tecovirimat) Approval Signals Hope Against Orthopoxvirus ThreatsIn a landmark decision, SIGA Technologies has announced that its antiviral treatment, TEPOXX (tecovirimat), has been officially approv...

SIGA Technologies, Inc. a prominent player in the pharmaceutical sector specializing in infectious diseases, has announced a significant agreement to supply its antiviral drug TPOXX (tecovirimat) to Morocco. This develo...

In a significant development within the pharmaceutical sector, SIGA Technologies, Inc. has been awarded a new contract by the U.S. Department of Defense (DOD) valued at approximately $9 million for the procurement of it...

Topline Results from PALM 007 Study of SIGA s Tecovirimat in Treatment of Monkeypox (Mpox) Released: Implications and Future Directions The National Institutes of Health (NIH), through its National Institute of Allergy...

U.S. Government Orders $113 Million Worth of Oral TPOXX from SIGA to Bolster Orthopoxvirus Preparedness In a resounding endorsement of ongoing public health and biosecurity initiatives, SIGA Technologies, Inc. (NASDAQ:...

: SIGA Technologies, Inc., a pharmaceutical company specializing in health security solutions, has announced an agreement to sell its antiviral drug, TPOXX, to member states of the Association of Southeast Asian Nations...

Introducing Larry Miller: SIGA Technologies Latest Addition Bolsters Legal Team in Pursuit of Health Security Excellence : March 25, 2024Publication: In the ever-evolving landscape of health security and infectious dise...

SIGA Technologies, Inc. (SIGA), a prominent pharmaceutical company specializing in the health security market, has recently shared news of the appointment of Dr. Diem Nguyen as their new Chief Executive Officer (CEO). W...